eXoZymes Revolutionizes Biomanufacturing with Breakthrough NCT Process
The biotechnology industry has witnessed significant advancements in recent times, with companies pushing the boundaries of innovation. eXoZymes, a pioneering player in this space, has made a groundbreaking announcement that is set to revolutionize the way natural products are manufactured.
During its Q2 2026 quarterly investor call, eXoZymes shared exciting news about its next-generation biomanufacturing capabilities, specifically related to the production of NCT (a highly valuable molecule found in nature). The company's R&D team and product development teams have been working tirelessly, achieving remarkable success that sets them up for success with NCT.
According to Tyler Korman, CSO and co-founder of eXoZymes, the company has made tremendous progress in productivity. In a pilot scale campaign conducted with Cayman Chemical, they produced over 500 grams of high-purity NCT at 99.6% purity, with 99% of the feedstock converted to product. This achievement answers the fundamental question any manufacturer asks: "Does this chemistry work outside our lab in someone else's hands at scale?"
However, as Korman emphasized, process reliability is not enough; it must also be efficient and cost-effective. To address these concerns, eXoZymes focused on improving productivity. The results are staggering, with the company now able to produce about 67% more NCT out of every liter of reaction volume than in the pilot run. Moreover, the reaction finishes about 5 times faster, which is a significant reduction in time and cost.
The most impressive aspect of this breakthrough is that the process is now roughly 10 times more productive than the initial pilot run. This achievement makes NCT economically attractive and strengthens the pathway toward technology transfer. eXoZymes believes that greater productivity and a simplified process will make it easier to collaborate with partners, ensuring a smooth scale-up.
Furthermore, Damien's presentation on partner selection highlighted the company's focus on building strong communication channels and shared commitments to problem-solving. This approach has been instrumental in selecting a manufacturing partner who can help execute the next stage of commercialization. The success of eXoZymes is not just about achieving milestones but also about fostering meaningful relationships that will propel their technology forward.
eXoZymes' achievement in biomanufacturing sets a new standard for innovation and collaboration. As the company continues to push boundaries, it becomes increasingly evident that their work has far-reaching implications for various industries, including nutraceuticals and pharmaceuticals. With its commitment to groundbreaking research and development, eXoZymes is poised to revolutionize the way we manufacture natural products.
